Molecular control of capillary morphogenesis and maturation by recognition and remodeling of the extracellular matrix: functional roles of endothelial cells and pericytes in health and disease

References

• Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464–78
   PubMed Web of Science ®Google Scholar
• Davis GE, Stratman AN, Sacharidou A, Koh W. Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting. Int Rev Cell Mol Biol 2011;288:101–65
   PubMed Web of Science ®Google Scholar
• Senger DR, Davis GE. Angiogenesis. Cold Spring Harb Perspect Biol 2011;3:a005090
   PubMed Web of Science ®Google Scholar
• Stratman AN, Davis GE. Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization. Microsc Microanal 2012;18:68–80
   PubMed Web of Science ®Google Scholar
• Xu K, Cleaver O. Tubulogenesis during blood vessel formation. Semin Cell Dev Biol 2011;22:993–1004
   PubMed Web of Science ®Google Scholar
• Swift MR, Weinstein BM. Arterial-venous specification during development. Circ Res 2009;104:576–88
   PubMed Web of Science ®Google Scholar
• Herbert SP, Stainier DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 2011;12:551–64
   PubMed Web of Science ®Google Scholar
• Kume T. Specification of arterial, venous, and lymphatic endothelial cells during embryonic development. Histol Histopathol 2010;25:637–46
   PubMed Web of Science ®Google Scholar
• Rocha SF, Adams RH. Molecular differentiation and specialization of vascular beds. Angiogenesis 2009;12:139–47
   PubMed Web of Science ®Google Scholar
• Davis GE. Molecular regulation of vasculogenesis and angiogenesis: recent advances and future directions. In: Homeister JW, Willis MS, eds. Molecular and translational vascular medicine. New York: Springer; 2012:169–206
   Google Scholar
• Ramasamy SK, Kusumbe AP, Adams RH. Regulation of tissue morphogenesis by endothelial cell-derived signals. Trends Cell Biol 2015;25:148–57
   PubMed Web of Science ®Google Scholar
• Cleaver O, Dor Y. Vascular instruction of pancreas development. Development 2012;139:2833–43
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646–74
   PubMed Web of Science ®Google Scholar
• Nagy JA, Dvorak AM, Dvorak HF. Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb Perspect Med 2012;2:a006544
   PubMed Web of Science ®Google Scholar
• Prieto D, Contreras C, Sanchez A. Endothelial dysfunction, obesity and insulin resistance. Curr Vasc Pharmacol 2014;12:412–26
   PubMed Web of Science ®Google Scholar
• Schrimpf C, Duffield JS. Mechanisms of fibrosis: the role of the pericyte. Curr Opin Nephrol Hypertens 2011;20:297–305
   PubMed Web of Science ®Google Scholar
• van Hinsbergh VW. Endothelium – role in regulation of coagulation and inflammation. Semin Immunopathol 2012;34:93–106
   PubMed Web of Science ®Google Scholar
• Trojanowska M. Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat Rev Rheumatol 2010;6:453–60
   PubMed Web of Science ®Google Scholar
• Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 2009;335:165–89
   PubMed Web of Science ®Google Scholar
• Fligny C, Duffield JS. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction. Curr Opin Rheumatol 2013;25:78–86
   PubMed Web of Science ®Google Scholar
• Hammes HP. Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 2005;37 Suppl 1:39–43
   PubMed Web of Science ®Google Scholar
• Karaca U, Schram MT, Houben AJ, Muris DM, Stehouwer CD. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diabetes Res Clin Pract 2014;103:382–7
   PubMed Web of Science ®Google Scholar
• Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002;160:985–1000
   PubMed Web of Science ®Google Scholar
• Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald DM. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003;163:1801–15
   PubMed Web of Science ®Google Scholar
• Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 2009;118:5–36
   PubMed Web of Science ®Google Scholar
• Ostergaard L, Aamand R, Gutierrez-Jimenez E, Ho YC, Blicher JU, Madsen SM, Nagenthiraja K, Dalby RB, Drasbek KR, Moller A, Braengaard H, Mouridsen K, Jespersen SN, Jensen MS, West MJ. The capillary dysfunction hypothesis of Alzheimer's disease. Neurobiol Aging 2013;34:1018–31
   PubMed Web of Science ®Google Scholar
• Perlmutter LS, Chui HC. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull 1990;24:677–86
   PubMed Web of Science ®Google Scholar
• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689–701
   PubMed Web of Science ®Google Scholar
• Weis SM. Vascular permeability in cardiovascular disease and cancer. Curr Opin Hematol 2008;15:243–9
   PubMed Web of Science ®Google Scholar
• Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011;21:193–215
   PubMed Web of Science ®Google Scholar
• Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009;114:5091–101
   PubMed Web of Science ®Google Scholar
• Stratman AN, Schwindt AE, Malotte KM, Davis GE. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 2010;116:4720–30
   PubMed Web of Science ®Google Scholar
• Bowers SL, Meng CX, Davis MT, Davis GE. Investigating human vascular tube morphogenesis and maturation using endothelial cell-pericyte co-cultures and a doxycycline-inducible genetic system in 3D extracellular matrices. Methods Mol Biol 2015;1189:171–89
   PubMedGoogle Scholar
• Datta A, Bryant DM, Mostov KE. Molecular regulation of lumen morphogenesis. Curr Biol 2011;21:R126–36
   PubMed Web of Science ®Google Scholar
• Bryant DM, Mostov KE. From cells to organs: building polarized tissue. Nat Rev Mol Cell Biol 2008;9:887–901
   PubMed Web of Science ®Google Scholar
• Iruela-Arispe ML, Davis GE. Cellular and molecular mechanisms of vascular lumen formation. Dev Cell 2009;16:222–31
   PubMed Web of Science ®Google Scholar
• Sacharidou A, Stratman AN, Davis GE. Molecular mechanisms controlling vascular lumen formation in three-dimensional extracellular matrices. Cells Tissues Organs 2012;195:122–43
   PubMed Web of Science ®Google Scholar
• Koh W, Mahan RD, Davis GE. Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling. J Cell Sci 2008;121:989–1001
   PubMed Web of Science ®Google Scholar
• Koh W, Sachidanandam K, Stratman AN, Sacharidou A, Mayo AM, Murphy EA, Cheresh DA, Davis GE. Formation of endothelial lumens requires a coordinated PKCɛ-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation. J Cell Sci 2009;122:1812–22
   PubMed Web of Science ®Google Scholar
• Xu K, Sacharidou A, Fu S, Chong DC, Skaug B, Chen ZJ, Davis GE, Cleaver O. Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling. Dev Cell 2011;20:1–14
   PubMed Web of Science ®Google Scholar
• Yuan L, Sacharidou A, Stratman AN, Le Bras A, Zwiers PJ, Spokes K, Bhasin M, Shih SC, Nagy JA, Molema G, Aird WC, Davis GE, Oettgen P. RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG. Blood 2011;118:1145–53
   PubMed Web of Science ®Google Scholar
• Bayless KJ, Davis GE. The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J Cell Sci 2002;115:1123–36
   PubMed Web of Science ®Google Scholar
• Saunders WB, Bohnsack BL, Faske JB, Anthis NJ, Bayless KJ, Hirschi KK, Davis GE. Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol 2006;175:179–91
   PubMed Web of Science ®Google Scholar
• Stratman AN, Saunders WB, Sacharidou A, Koh W, Fisher KE, Zawieja DC, Davis MJ, Davis GE. Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. Blood 2009;114:237–47
   PubMed Web of Science ®Google Scholar
• Dejana E, Vestweber D. The role of VE-cadherin in vascular morphogenesis and permeability control. Prog Mol Biol Transl Sci 2013;116:119–44
   PubMed Web of Science ®Google Scholar
• Sacharidou A, Koh W, Stratman AN, Mayo AM, Fisher KE, Davis GE. Endothelial lumen signaling complexes control 3D matrix-specific tubulogenesis through interdependent Cdc42- and MT1-MMP-mediated events. Blood 2010;115:5259–69
   Google Scholar
• Zovein AC, Luque A, Turlo KA, Hofmann JJ, Yee KM, Becker MS, Fassler R, Mellman I, Lane TF, Iruela-Arispe ML. Beta1 integrin establishes endothelial cell polarity and arteriolar lumen formation via a Par3-dependent mechanism. Dev Cell 2010;18:39–51
   PubMed Web of Science ®Google Scholar
• Lampugnani MG, Orsenigo F, Rudini N, Maddaluno L, Boulday G, Chapon F, Dejana E. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 2010;123:1073–80
   PubMed Web of Science ®Google Scholar
• Smith AO, Bowers SL, Stratman AN, Davis GE. Hematopoietic stem cell cytokines and fibroblast growth factor-2 stimulate human endothelial cell-pericyte tube co-assembly in 3D fibrin matrices under serum-free defined conditions. PLoS One 2013;8:e85147
   PubMed Web of Science ®Google Scholar
• Davis GE, Camarillo CW. An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res 1996;224:39–51
   PubMed Web of Science ®Google Scholar
• Fisher KE, Pop A, Koh W, Anthis NJ, Saunders WB, Davis GE. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. Mol Cancer 2006;5:69
   PubMed Web of Science ®Google Scholar
• Fisher KE, Sacharidou A, Stratman AN, Mayo AM, Fisher SB, Mahan RD, Davis MJ, Davis GE. MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices. J Cell Sci 2009;122:4558–69
   PubMed Web of Science ®Google Scholar
• Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 2003;114:171–80
   PubMed Web of Science ®Google Scholar
• Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003;9:407–15
   PubMed Web of Science ®Google Scholar
• Stratman AN, Davis MJ, Davis GE. VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood 2011;117:3709–19
   PubMed Web of Science ®Google Scholar
• Davis GE, Kim DJ, Meng CX, Norden PR, Speichinger KR, Davis MT, Smith AO, Bowers SL, Stratman AN. Control of vascular tube morphogenesis and maturation in 3D extracellular matrices by endothelial cells and pericytes. Methods Mol Biol 2013;1066:17–28
   PubMedGoogle Scholar
• Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, Maxwell SA, Davis GE. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci 2001;114:2755–73
   PubMed Web of Science ®Google Scholar
• Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost 2007;5 (Suppl 1):32–40
   PubMed Web of Science ®Google Scholar
• Hynes RO. The extracellular matrix: not just pretty fibrils. Science 2009;326:1216–19
   PubMed Web of Science ®Google Scholar
• Wang X, Harris RE, Bayston LJ, Ashe HL. Type IV collagens regulate BMP signalling in Drosophila. Nature 2008;455:72–7
   PubMed Web of Science ®Google Scholar
• Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, Sobel M. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 2002;91:25–31
   PubMed Web of Science ®Google Scholar
• Xu Y, Yu Q. Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biol Chem 2001;276:34990–8
   PubMed Web of Science ®Google Scholar
• Cascone I, Napione L, Maniero F, Serini G, Bussolino F. Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol 2005;170:993–1004
   PubMed Web of Science ®Google Scholar
• Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest 2014;124:2299–306
   PubMed Web of Science ®Google Scholar
• Apte MV, Pirola RC, Wilson JS. Pancreatic stellate cells: a starring role in normal and diseased pancreas. Front Physiol 2012;3:344
   PubMed Web of Science ®Google Scholar
• Carloni V, Luong TV, Rombouts K. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever. Liver Int 2014;34:834–43
   PubMed Web of Science ®Google Scholar
• Coulouarn C, and Clement B. Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma. J Hepatol 2014;60:1306–9
   PubMed Web of Science ®Google Scholar
• Hellerbrand C. Hepatic stellate cells – the pericytes in the liver. Pflugers Arch 2013;465:775–8
   PubMed Web of Science ®Google Scholar
• Kolodecik T, Shugrue C, Ashat M, Thrower EC. Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front Physiol 2013;4:415
   Web of Science ®Google Scholar
• Yin C, Evason KJ, Asahina K, Stainier DY. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest 2013;123:1902–10
   PubMed Web of Science ®Google Scholar
• Smith SW, Schrimpf C, Parekh DJ, Venkatachalam M, Duffield JS. Kidney pericytes: a novel therapeutic target in interstitial fibrosis. Histol Histopathol 2012;27:1503–14
   PubMed Web of Science ®Google Scholar
• Kadin ME. Pathology of Hodgkin's disease. Curr Opin Oncol 1994;6:456–63
   PubMedGoogle Scholar
• Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009;139:891–906
   PubMed Web of Science ®Google Scholar
• Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007;117:50–9
   PubMed Web of Science ®Google Scholar
• Dahlback B, Villoutreix BO. Molecular recognition in the protein C anticoagulant pathway. J Thromb Haemost 2003;1:1525–34
   PubMed Web of Science ®Google Scholar
• Esmon CT. The endothelial protein C receptor. Curr Opin Hematol 2006;13:382–5
   PubMed Web of Science ®Google Scholar
• Mohan Rao LV, Esmon CT, Pendurthi UR. Endothelial cell protein C receptor: a multiliganded and multifunctional receptor. Blood 2014;124:1553–62
   PubMed Web of Science ®Google Scholar
• Xue M, Minhas N, Chow SO, Dervish S, Sambrook PN, March L, Jackson CJ. Endogenous protein C is essential for the functional integrity of human endothelial cells. Cell Mol Life Sci 2010;67:1537–46
   PubMed Web of Science ®Google Scholar
• Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009;16:209–21
   PubMed Web of Science ®Google Scholar
• Giannotta M, Trani M, Dejana E. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell 2013;26:441–54
   PubMed Web of Science ®Google Scholar
• Burgey C, Kern WV, Romer W, Sakinc T, Rieg S. The innate defense antimicrobial peptides hBD3 and RNase7 are induced in human umbilical vein endothelial cells by classical inflammatory cytokines but not Th17 cytokines. Microbes Infect 2015;17:353–9
   PubMed Web of Science ®Google Scholar
• Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818–25
   PubMed Web of Science ®Google Scholar
• Olas B. Gasomediators (NO, CO, and HS) and their role in hemostasis and thrombosis. Clin Chim Acta 2015;445:115–21
   PubMed Web of Science ®Google Scholar
• Maier CL, Pober JS. Human placental pericytes poorly stimulate and actively regulate allogeneic CD4 T cell responses. Arterioscler Thromb Vasc Biol 2011;31:183–9
   PubMed Web of Science ®Google Scholar
• Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 2009;16:94–112
   PubMed Web of Science ®Google Scholar
• Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A, Aiello LP, Kern TS, King GL. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 2009;15:1298–306
   PubMed Web of Science ®Google Scholar
• Nagy JA, Chang SH, Dvorak AM, Dvorak HF. Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer 2009;100:865–9
   PubMed Web of Science ®Google Scholar
• Davis GE, Senger DR. Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression. Curr Opin Hematol 2008;15:197–203
   PubMed Web of Science ®Google Scholar
• Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58–62
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 2011;10:417–27
   PubMed Web of Science ®Google Scholar
• Goel S, Wong AH, Jain RK. Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. Cold Spring Harb Perspect Med 2012;2:a006486
   PubMed Web of Science ®Google Scholar
• Mancuso MR, Davis R, Norberg SM, O'Brien S, Sennino B, Nakahara T, Yao VJ, Inai T, Brooks P, Freimark B, et al. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 2006;116:2610–21
   PubMed Web of Science ®Google Scholar
• Hoang MV, Smith LE, Senger DR. Moderate GSK-3beta inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy. Angiogenesis 2010;13:269–77
   PubMed Web of Science ®Google Scholar
• Hoang MV, Nagy JA, Senger DR. Cdc42-mediated inhibition of GSK-3beta improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis. Microvasc Res 2011;81:34–43
   PubMed Web of Science ®Google Scholar
• Hoang MV, Nagy JA, Senger DR. Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. Blood 2011;117:1751–60
   PubMed Web of Science ®Google Scholar
• Falcon BL, Hashizume H, Koumoutsakos P, Chou J, Bready JV, Coxon A, Oliner JD, McDonald DM. Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels. Am J Pathol 2009;175:2159–70
   PubMed Web of Science ®Google Scholar
• Sawada J, Urakami T, Li F, Urakami A, Zhu W, Fukuda M, Li DY, Ruoslahti E, Komatsu M. Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. Cancer Cell 2012;22:235–49
   PubMed Web of Science ®Google Scholar
• Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, Ruiz de Almodovar C, De Smet F, Vinckier S, Aragones J, Debackere K, Luttun A, Wyns S, Jordan B, Pisacane A, Gallez B, Lampugnani MG, Dejana E, Simons M, Ratcliffe P, Maxwell P, Carmeliet P. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009;136:839–51
   PubMed Web of Science ®Google Scholar
• Magrini E, Villa A, Angiolini F, Doni A, Mazzarol G, Rudini N, Maddaluno L, Komuta M, Topal B, Prenen H, Schachner M, Confalinieri S, Dejana E, Bianchi F, Mazzone M, Cavallaro U. Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization. J Clin Invest 2014;124:4335–50
   PubMed Web of Science ®Google Scholar